Myasthenia gravis is a relatively uncommon antoimmune disorder of neur
omuscular transmission. Surgical therapy plays an important role in ad
dition to medical treatment. Follow-up results of 52 patients with thy
mectomy are presented. Between 1984-1996 thymectomy via median sternot
omy was performed in 52 patients with myasthenia gravis (female = 28,
male = 24). The score described by Ossermann and Genkins was used for
classification. According to this classification, we found 12 patients
in class III, 21 in class IIA, 17 in class IIB and 2 in class III, re
spectively. A thymoma was found in 19, follicular lymphoid hyperplasia
in 24 and an atrophic thymus in 9 cases, respectively. There was no m
ortality. Severe postoperative complications consisted of bleeding and
reoperation in one patient and another patient developed a sternal in
stability with consecutive operative refixation. Follow-up evaluation
after a mean period of 36 months (min. 6 months, max. 130 months) reve
aled a relief of myasthenic symptoms in 37 patients. Thymectomy is eff
ective in the treatment of myasthenia gravis with a low complication r
ate.